Trial of Hematopoietic Stem Cells in Acute Myocardial Infarction | Clinical Trial - TECAM

Description:

The goal of the trial was to evaluate three different treatment strategies involving cell therapy after reperfusion for ST-segment elevation myocardial infarction (STEMI).

Contribution to the Literature: The TECAM trial failed to show that cell therapy after reperfusion for acute myocardial infarction improves left ventricular ejection fraction.